Piperidin-4-il-urea derivatives; pharmacodynamic synthesis; and as Grelina receptor antagonists in the treatment of obesity, eating disorders, diabetes, cancer-induced thrombosis, congestive heart failure, etc.
Disclosed are compounds, compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the ghrelin receptor. The compounds have the general formula (I):COMPUESTOS DERIVADOS DE (PIPERIDIN-4-IL)-UREAS; COMPOSICION FARMACEUTICA; Y USO COMO ANTAGONISTAS DEL RECEPTOR GRELINA EN EL TRATAMIENTO DE LA OBESIDAD, TRASTORNOS ALIMENTICIOS, DIABETES, CAQUEXIA CAUSADA POR EL CANCER, INSUFICIENCIA CARDIACA CONGESTIVA, ENTRE OTRAS.